Andrew Blight is CSO at ACORDA THERAPEUTICS INC (ACOR). They have made 8 open-market trades across 1 company since 2006, most recently 2017-03-01.
CIK 0001352453
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACOR | 78,594 | $52K |
Shares reported on the most recent Form 4, priced at the 2017-03-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACOR | SELL | 2017-02-09 | 2017-02-13 | $22.41 | $3.0M | +5.3% | +18.8% | -33.8% |
| ACOR | SELL | 2016-12-01 | 2016-12-05 | $20.76 | $202K | +0.7% | -3.5% | +27.8% |
| ACOR | SELL · 10b5-1 | 2015-11-20 | 2015-11-23 | $37.47 | $19K | -8.7% | +0.7% | -17.0% |
| ACOR | SELL · 10b5-1 | 2015-10-19 | 2015-10-21 | $30.87 | $1.0M | -8.7% | +0.7% | -10.5% |
| ACOR | SELL · 10b5-1 | 2015-09-21 | 2015-09-23 | $31.30 | $410K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2014-10-20 | 2014-10-22 | $32.08 | $1.7M | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2013-12-02 | 2013-12-04 | $33.51 | $305K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2013-07-19 | 2013-07-23 | $37.82 | $730K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2012-12-03 | 2012-12-05 | $24.20 | $174K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2012-10-22 | 2012-10-24 | $23.08 | $219K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2011-12-01 | 2011-12-05 | $22.92 | $160K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2010-03-02 | 2010-03-03 | $32.21 | $134K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2010-02-02 | 2010-02-03 | $30.00 | $136K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2009-12-01 | 2009-12-02 | $24.51 | $110K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL | 2008-06-12 | 2008-06-16 | $31.50 | $277K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL | 2008-06-12 | 2008-06-16 | $31.72 | $57K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL | 2008-06-12 | 2008-06-16 | $30.65 | $276K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL | 2008-06-11 | 2008-06-13 | $31.53 | $25K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2008-06-05 | 2008-06-09 | $30.36 | $112K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2008-06-05 | 2008-06-09 | $32.56 | $173K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2008-06-05 | 2008-06-09 | $32.25 | $226K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2008-06-05 | 2008-06-09 | $31.82 | $127K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2008-04-07 | 2008-04-09 | $18.36 | $66K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2008-03-10 | 2008-03-12 | $17.92 | $72K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2008-02-15 | 2008-02-19 | $23.37 | $105K | -8.7% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.